{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:06:41Z","timestamp":1787062001854,"version":"build-2736575974"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,17]],"date-time":"2016-12-17T00:00:00Z","timestamp":1481932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"College of Pharmacy Research Centre, Deanship of Scientific Research, King Saud University"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jsps.2016.12.007","type":"journal-article","created":{"date-parts":[[2016,12,26]],"date-time":"2016-12-26T14:31:53Z","timestamp":1482762713000},"page":"819-822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Use of the guidelines directed medical therapy after coronary artery bypass graft surgery in Saudi Arabia"],"prefix":"10.1007","volume":"25","author":[{"given":"Khalid A.","family":"Alburikan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakan I.","family":"Nazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"9","key":"10.1016\/j.jsps.2016.12.007_b0005","first-page":"1165","article-title":"Coronary artery disease in Saudi Arabia","volume":"25","author":"Al-Nozha","year":"2004","journal-title":"Saudi Med. J."},{"key":"10.1016\/j.jsps.2016.12.007_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2008.09.026","article-title":"Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study","volume":"157","author":"Bi","year":"2009","journal-title":"Am. Heart J."},{"key":"10.1016\/j.jsps.2016.12.007_b0015","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1093\/eurheartj\/ehs367","article-title":"Incidence and multivariable correlates of long-term mortality in patients treated with surgical or percutaneous revascularization in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial","volume":"33","author":"Farooq","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jsps.2016.12.007_b0020","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.athoracsur.2006.10.046","article-title":"Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery","volume":"83","author":"Goyal","year":"2007","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.jsps.2016.12.007_b0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jtcvs.2011.10.015","article-title":"2011 ACCF\/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"143","author":"Hillis","year":"2012","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.jsps.2016.12.007_b0030","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/ejcts\/ezu366","volume":"46","author":"Kolh","year":"2014","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.jsps.2016.12.007_b0035","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1161\/CIR.0000000000000182","article-title":"Secondary prevention after coronary artery bypass graft surgery: a scientific statement from the American Heart Association","volume":"131","author":"Kulik","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jsps.2016.12.007_b0040","first-page":"157","article-title":"Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial","volume":"102","author":"Knatterud","year":"2000","journal-title":"Post CABG Investigat. Circulat."},{"key":"10.1016\/j.jsps.2016.12.007_b0045","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa020798","article-title":"Multicenter study of perioperative Ischemia Research group. Aspirin and mortality from coronary bypass surgery","volume":"347","author":"Mangano","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsps.2016.12.007_b0050","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0002-9149(00)01428-4","article-title":"Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia","volume":"87","author":"Oosterga","year":"2001","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.jsps.2016.12.007_b0055","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1056\/NEJM199701163360301","article-title":"The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts","volume":"336","author":"Post Coronary Artery Bypass Graft Trial Investigators","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsps.2016.12.007_b0060","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.jacc.2011.10.824","volume":"58","author":"Smith","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jsps.2016.12.007_b0065","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1093\/oxfordjournals.eurheartj.a060835","article-title":"Effect of metoprolol on death and cardiac events during a 2-year period after coronary artery bypass grafting","volume":"16","author":"The MACB Study Group","year":"1995","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jsps.2016.12.007_b0070","first-page":"1191","article-title":"Ischemia Management with Accupril post bypass Graft via Inhibition of angiotensin converting enzyme (IMAGINE): a multicentre randomized trial \u2013 design and rationale","volume":"18","author":"Warnica","year":"2002","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.jsps.2016.12.007_b0075","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/CIR.0000000000000366","article-title":"Executive summary: heart disease and stroke statistics \u2013 2016 update: a report from the American heart association","volume":"133","author":"Writing Group Members","year":"2016","journal-title":"Circulation"}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016416301414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016416301414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T12:30:56Z","timestamp":1736166656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319016416301414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1319016416301414"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2016.12.007","relation":{},"ISSN":["1319-0164"],"issn-type":[{"value":"1319-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of the guidelines directed medical therapy after coronary artery bypass graft surgery in Saudi Arabia","name":"articletitle","label":"Article Title"},{"value":"Saudi Pharmaceutical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsps.2016.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}]}}